title: Health security preparedness and industry trends.
abstract: Given the number and diversity of risks in today's complex society, it is essential to focus on global risks that can be reduced through affordable, feasible approaches. Thus, the risks that should command the greatest focus are emergent infectious diseases. Fortunately, preparing responses to such threats can be entirely agnostic as to source or intent of the threat. This article considers the emergent infectious clinical threats, characterizes the steps that are essential to take to prepare for such threats, and discusses the roles that the biomedical industry should play in both the preparation for and response to such threats. The author assesses the readiness of the industry to play its role and suggests steps to consider to enable a more robust response.
authors: Stanley T
authors: ST
authors: Crooke
mesh_terms: D000890:Anti-Infective Agents; D035843:Biomedical Research / Q000191:economics / Q000639:trends*; D002959:Civil Defense / Q000379:methods; D021821:Communicable Diseases, Emerging / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control* / Q000635:transmission; D055808:Drug Discovery / Q000191:economics; D004345:Drug Industry / Q000191:economics / Q000639:trends*; D020869:Gene Expression Profiling; D019981:Health Care Sector / Q000639:trends*; D006801:Humans; D007113:Immunity, Innate; D058990:Molecular Targeted Therapy; D062205:Strategic Stockpile; D014612:Vaccines; D000078329:Workforce
chemical_list: D000890:Anti-Infective Agents; D014612:Vaccines